annual EBIT:
-$120.82M+$67.60M(+35.88%)Summary
- As of today (May 29, 2025), NVCR annual earnings before interest & taxes is -$120.82 million, with the most recent change of +$67.60 million (+35.88%) on December 31, 2024.
- During the last 3 years, NVCR annual EBIT has fallen by -$72.18 million (-148.42%).
- NVCR annual EBIT is now -438.58% below its all-time high of $35.68 million, reached on December 31, 2020.
Performance
NVCR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$37.87M-$24.24M(-177.87%)Summary
- As of today (May 29, 2025), NVCR quarterly earnings before interest & taxes is -$37.87 million, with the most recent change of -$24.24 million (-177.87%) on March 31, 2025.
- Over the past year, NVCR quarterly EBIT has increased by +$3.65 million (+8.80%).
- NVCR quarterly EBIT is now -317.93% below its all-time high of $17.38 million, reached on December 31, 2020.
Performance
NVCR quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$117.16M+$3.65M(+3.03%)Summary
- As of today (May 29, 2025), NVCR TTM earnings before interest & taxes is -$117.16 million, with the most recent change of +$3.65 million (+3.03%) on March 31, 2025.
- Over the past year, NVCR TTM EBIT has increased by +$52.53 million (+30.95%).
- NVCR TTM EBIT is now -400.60% below its all-time high of $38.98 million, reached on March 31, 2021.
Performance
NVCR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NVCR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +35.9% | +8.8% | +30.9% |
| 3 y3 years | -148.4% | -4597.9% | -137.4% |
| 5 y5 years | -2492.5% | -1019.9% | -1604.6% |
NVCR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -148.4% | +35.9% | -4597.9% | +39.6% | -137.4% | +45.0% |
| 5 y | 5-year | -438.6% | +35.9% | -317.9% | +39.6% | -400.6% | +45.0% |
| alltime | all time | -438.6% | +35.9% | -317.9% | +39.6% | -400.6% | +45.0% |
NVCR EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$37.87M(+177.9%) | -$117.16M(-3.0%) |
| Dec 2024 | -$120.82M(-35.9%) | -$13.63M(-57.5%) | -$120.82M(+5.6%) |
| Sep 2024 | - | -$32.09M(-4.4%) | -$114.46M(-18.6%) |
| Jun 2024 | - | -$33.58M(-19.1%) | -$140.61M(-17.1%) |
| Mar 2024 | - | -$41.52M(+471.3%) | -$169.69M(-9.9%) |
| Dec 2023 | -$188.42M(+140.0%) | -$7.27M(-87.5%) | -$188.42M(-11.6%) |
| Sep 2023 | - | -$58.24M(-7.0%) | -$213.12M(+18.7%) |
| Jun 2023 | - | -$62.66M(+4.0%) | -$179.49M(+30.1%) |
| Mar 2023 | - | -$60.25M(+88.5%) | -$137.96M(+75.7%) |
| Dec 2022 | -$78.51M(+61.4%) | -$31.97M(+29.9%) | -$78.51M(+5.7%) |
| Sep 2022 | - | -$24.61M(+16.5%) | -$74.25M(+27.6%) |
| Jun 2022 | - | -$21.13M(+2521.3%) | -$58.19M(+17.9%) |
| Mar 2022 | - | -$806.00K(-97.1%) | -$49.35M(+1.5%) |
| Dec 2021 | -$48.63M(-236.3%) | -$27.70M(+223.9%) | -$48.63M(+1266.2%) |
| Sep 2021 | - | -$8.55M(-30.4%) | -$3.56M(-117.8%) |
| Jun 2021 | - | -$12.29M(>+9900.0%) | $20.01M(-48.7%) |
| Mar 2021 | - | -$88.00K(-100.5%) | $38.98M(+9.2%) |
| Dec 2020 | $35.68M(+606.6%) | $17.38M(+15.7%) | $35.68M(+46.1%) |
| Sep 2020 | - | $15.02M(+125.3%) | $24.43M(+84.2%) |
| Jun 2020 | - | $6.67M(-297.2%) | $13.26M(+70.3%) |
| Mar 2020 | - | -$3.38M(-155.3%) | $7.79M(+54.2%) |
| Dec 2019 | $5.05M | $6.12M(+58.7%) | $5.05M(-188.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $3.85M(+222.3%) | -$5.73M(-61.4%) |
| Jun 2019 | - | $1.20M(-119.5%) | -$14.83M(-35.8%) |
| Mar 2019 | - | -$6.12M(+31.1%) | -$23.11M(-22.1%) |
| Dec 2018 | -$29.67M(-22.4%) | -$4.67M(-11.1%) | -$29.67M(+4.4%) |
| Sep 2018 | - | -$5.25M(-26.0%) | -$28.42M(-2.3%) |
| Jun 2018 | - | -$7.08M(-44.1%) | -$29.09M(-22.5%) |
| Mar 2018 | - | -$12.68M(+271.3%) | -$37.54M(-1.8%) |
| Dec 2017 | -$38.24M(-66.9%) | -$3.41M(-42.3%) | -$38.24M(-27.7%) |
| Sep 2017 | - | -$5.92M(-61.9%) | -$52.91M(-29.7%) |
| Jun 2017 | - | -$15.53M(+16.1%) | -$75.25M(-22.4%) |
| Mar 2017 | - | -$13.37M(-26.1%) | -$96.96M(-16.1%) |
| Dec 2016 | -$115.53M(+10.3%) | -$18.09M(-36.0%) | -$115.53M(-10.3%) |
| Sep 2016 | - | -$28.27M(-24.1%) | -$128.82M(+3.2%) |
| Jun 2016 | - | -$37.24M(+16.6%) | -$124.80M(+8.7%) |
| Mar 2016 | - | -$31.94M(+1.8%) | -$114.77M(+9.5%) |
| Dec 2015 | -$104.77M(+30.5%) | -$31.38M(+29.5%) | -$104.77M(+8.6%) |
| Sep 2015 | - | -$24.24M(-10.9%) | -$96.50M(+7.0%) |
| Jun 2015 | - | -$27.21M(+24.0%) | -$90.17M(+43.2%) |
| Mar 2015 | - | -$21.95M(-5.0%) | -$62.96M(+53.5%) |
| Dec 2014 | -$80.26M(+14.9%) | -$23.11M(+29.1%) | -$41.02M(+129.1%) |
| Sep 2014 | - | -$17.91M | -$17.91M |
| Dec 2013 | -$69.86M | - | - |
FAQ
- What is NovoCure Limited annual earnings before interest & taxes?
- What is the all time high annual EBIT for NovoCure Limited?
- What is NovoCure Limited annual EBIT year-on-year change?
- What is NovoCure Limited quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for NovoCure Limited?
- What is NovoCure Limited quarterly EBIT year-on-year change?
- What is NovoCure Limited TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for NovoCure Limited?
- What is NovoCure Limited TTM EBIT year-on-year change?
What is NovoCure Limited annual earnings before interest & taxes?
The current annual EBIT of NVCR is -$120.82M
What is the all time high annual EBIT for NovoCure Limited?
NovoCure Limited all-time high annual earnings before interest & taxes is $35.68M
What is NovoCure Limited annual EBIT year-on-year change?
Over the past year, NVCR annual earnings before interest & taxes has changed by +$67.60M (+35.88%)
What is NovoCure Limited quarterly earnings before interest & taxes?
The current quarterly EBIT of NVCR is -$37.87M
What is the all time high quarterly EBIT for NovoCure Limited?
NovoCure Limited all-time high quarterly earnings before interest & taxes is $17.38M
What is NovoCure Limited quarterly EBIT year-on-year change?
Over the past year, NVCR quarterly earnings before interest & taxes has changed by +$3.65M (+8.80%)
What is NovoCure Limited TTM earnings before interest & taxes?
The current TTM EBIT of NVCR is -$117.16M
What is the all time high TTM EBIT for NovoCure Limited?
NovoCure Limited all-time high TTM earnings before interest & taxes is $38.98M
What is NovoCure Limited TTM EBIT year-on-year change?
Over the past year, NVCR TTM earnings before interest & taxes has changed by +$52.53M (+30.95%)